CAR T-cell therapy – Why it’s too soon to speculate about a ‘cure’ for numerous myeloma
Categories
Kathlyn Stone is an associate editor at HealthNewsReview.org. She tweets as @KatKStone.
An experimental immunotherapy treatment for numerous myeloma from a biotech company in China captured broad attention at the just-concluded American Society of Clinical Oncology (ASCO) meeting. Continue reading CAR T-cell therapy – Why it – s too soon to speculate about a – cure – for numerous myeloma